-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SMwP3gG/pK9gZKTQPt/+RV8yh6gOyW7WxB8JuLePmY9Pc44s+eWLc6LA9jstAACh py9tVUkmzv5JBNOXF+AKBw== 0001140361-08-027515.txt : 20081210 0001140361-08-027515.hdr.sgml : 20081210 20081210171922 ACCESSION NUMBER: 0001140361-08-027515 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20081210 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20081210 DATE AS OF CHANGE: 20081210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FOREST LABORATORIES INC CENTRAL INDEX KEY: 0000038074 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 111798614 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05438 FILM NUMBER: 081241738 BUSINESS ADDRESS: STREET 1: 909 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212)421-7850 MAIL ADDRESS: STREET 1: 909 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 8-K 1 form8k.htm FOREST LABORATORIES 8-K 12-10-2008 form8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
__________________________________________

Pursuant to Section 13 or 15 (d) of
The Securities Exchange Act of 1934

December 10, 2008
Date of report (date of earliest event reported)

    FOREST LABORATORIES, INC.    
(Exact name of registrant as specified in its charter)

Delaware
  
1-5438
  
11-1798614
(State or other jurisdiction of incorporation or organization)
  
(Commission File Number)
  
(I.R.S. Employer Identification Number)
         
909 Third Avenue
      
10022-4731
New York, New York
      
(Zip code)
(Address of principal executive offices)
        

 
(212) 421-7850
  
 
(Registrant's telephone number, including area code)
  
     
 
None
  
 
(Former name or former address, if changed since last report)
  


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

£
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
£
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
£
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))
£
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 

Item 8.01   OTHER EVENTS

Forest Laboratories, Inc. (the “Company”) is participating in the Securities Exchange Commission’s XBRL (eXtensible Business Reporting Language) voluntary filing program.  In connection with this program, the Company has attached as Exhibit 100 to this Current Report on Form 8-K the following materials from its Quarterly Report on Form 10-Q for the Quarter ended June 30, 2008, filed with the Securities Exchange Commission on August 8, 2008, formatted in XBRL, excluding the notes to the financial statements: (i) Condensed Consolidated Statements of Income, (ii) Condensed Consolidated Balance Sheets, (iii) Condensed Consolidated Statements of Comprehensive Income, and (iv) Condensed Consolidated Statements of Cash Flows.

Users of this data are advised pursuant to Rule 401 of Regulation S-T that the financial information contained in the XBRL documents is unaudited and these are not the official publicly filed financial statements of the Company.  The purpose of submitting these XBRL formatted documents is to test the related format and technology and, as a result, investors should continue to rely on the official filed version of the furnished documents and not rely on the information in this Current Report on Form 8-K, including the Exhibit 100, in making investment decisions.

In accordance with Rule 402 of Regulation S-T, the information in this Current Report on Form 8-K, including Exhibit 100, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific references in such filing.

Item 9.01   Financial Statements and Exhibits.
 
(d)
Exhibits

The following exhibits are furnished herewith:

Exhibit No.
  
Exhibit Description
100
   The following financial statements from Forest Laboratories, Inc’s Quarterly Report on Form 10-Q for the three months ended June 30, 2008, filed on August 8, 2008, formatted in XBRL (eXtensive Business Reporting Language), excluding notes to the financial statements: (i) Condensed Consolidated Statements of Income, (ii) Condensed Consolidated Balance Sheets, (iii) Condensed Consolidated Statements of Comprehensive Income, and (iv) Condensed Consolidated Statements of Cash Flows.

 
 
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date:  December 10, 2008

 
 
Forest Laboratories, Inc.
  
 
(Registrant)
  
     
     
 
/s/ Francis I. Perier, Jr.
  
 
Francis I. Perier, Jr.
  
 
Senior Vice President - Finance and
  
 
Chief Financial Officer
  

 
Exhibit Index

Exhibit No.
  
Description
     
EX-100.INS
  
XBRL Instance Document
EX-100.SCH
  
XBRL Taxonomy Extension Schema Document
EX-100.PRE
  
XBRL Taxonomy Presentation Linkbase Document
EX-100.LAB
  
XBRL Taxonomy Label Linkbase Document
EX-100.CAL
  
XBRL Taxonomy Calculation Linkbase Document
     
     
 
 
EX-100.INS 2 frx-20080630.xml XBRL INSTANCE DOCUMENT Forest Laboratories 2008-06-30 Unaudited Forest Laboratories 2008-03-31 Forest Laboratories 2008-04-01 2008-06-30 Unaudited Forest Laboratories 2007-04-01 2007-06-30 Unaudited Forest Laboratories 2008-04-01 Unaudited Forest Laboratories 2007-04-01 Unaudited Forest Laboratories 2007-06-30 Unaudited iso4217:USD xbrli:shares 0 3372000 71517000 75636000 966844000 928274000 230129000 226095000 -121883000 47757000 13126000 11317000 314437000 343798000 -3638267000 -3407082000 5854413000 5611493000 101837000 223720000 400120000 445987000 992687000 833052000 833052000 563663000 621897000 -502398000 -827325000 316998000 349519000 0.79 0.83 159635000 58234000 45867000 -16047000 -545000 -170000 307043 319580 893745000 842616000 2980969000 2907504000 582609000 607821000 54153000 53377000 42145000 42142000 840085000 943972000 73997000 -229108000 49000 54000 27179000 9165000 0.79 0.84 716000 5543000 640909000 610825000 500841000 387105000 577565000 604201000 46747000 33260000 202000 18580000 197340000 186240000 210361000 198410000 -46063000 -32613000 1622000 1671000 0 0 -231185000 -86003000 50182000 16448000 -4670000 18584000 60360000 59778000 500618000 527787000 242920000 268162000 4588950000 4525367000 573510000 567331000 471201000 425138000 14504000 37517000 112112000 136908000 3736919000 3715317000 1444958000 1434172000 113736000 39211000 -922000 1979000 652407000 584476000 343116000 350037000 -377000 1874000 -13487000 -23025000 342955000 261328000 14965000 14965000 230394000 217294000 -6214000 -9604000 211122000 199225000 38231000 0 687300000 663625000 10587000 10676000 18230000 26738000 4588950000 4525367000 33670000 34592000 -230983000 -64051000 241998000 270141000 307912 321921 761000 815000 EX-100.SCH 3 frx-20080630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 124000 - Statement - Condensed Consolidated Statements of Income link:calculationLink link:presentationLink 104000 - Statement - Condensed Consolidated Balance Sheets link:calculationLink link:presentationLink 148400 - Statement - Condensed Consolidated Statements of Comprehensive Income link:calculationLink link:presentationLink 152200 - Statement - Condensed Consolidated Statements of Cash Flows link:calculationLink link:presentationLink EX-100.PRE 4 frx-20080630_pre.xml XBRL TAXONOMY PRESENTATION LINKBASE DOCUMENT EX-100.LAB 5 frx-20080630_lab.xml XBRL TAXONOMY LABEL LINKBASE DOCUMENT Accounts payable Accounts receivable, net Accrued expenses Accumulated other comprehensive income Less: accumulated depreciation Additional paid-in capital Cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Accounts receivable, net Income tax liabilities Inventories, net Other current assets Accounts payable Accrued expenses Common stock, $.10 par; shares authorized 1,000,000; issued 421,451 shares in June and 421,421 shares in March Comprehensive income Cost of sales Total current liabilities Deferred income tax (benefit) expense Net income per common share - diluted Effect of exchange rate changes on cash Stock-based compensation expense Income taxes payable Other assets License agreements, product rights and other intangibles, net Inventories, net Total liabilities and stockholders' equity Marketable securities Marketable securities Net cash used in financing activities Net cash provided by (used in) investing activities Net cash provided by operating activities Net income Increase in cash and cash equivalents Total other assets Total noncurrent liabilities Total revenue Other comprehensive (loss) income Unrealized holding (loss) gain arising during the period, net of tax Other current assets Other income Redemption of marketable securities Net proceeds from common stock options exercised by employees under stock option plans Property, plant and equipment, gross Property, plant and equipment, net Purchase of license agreements, product rights and other intangibles Purchase of marketable securities Purchase of property, plant and equipment Purchase of treasury stock Retained earnings Contract revenue Net sales Selling, general and administrative Income taxes Total current assets Weighted average number of common shares outstanding - diluted Weighted average number of common shares outstanding - basic Research and development Total assets Interest income Deferred income taxes Deferred income taxes Deferred income taxes Machinery, equipment and other Treasury stock, at cost (116,668 shares in June and 110,014 shares in March) Net income per common share - basic Other assets Total operating income Income before income tax expense Foreign currency translation gains (losses) Total stockholders' equity Income tax expense Series preferred stock, $1.00 par; shares authorized 1,000; no shares issued or outstanding Tax benefit realized from the exercise of stock options by employees Foreign currency transaction gain Income tax liabilities Land and buildings Carrying amount as of the balance sheet date of real estate held for productive use. This excludes land held for sale. Carrying amount as of the balance sheet date of long-lived, depreciable assets that include building structures held for productive use including any addition, improvement, or renovation to the structure, such as interior masonry, interior flooring, electrical, and plumbing. Amortization and impairments Supplemental Disclosures of Cash Flow Information [Abstract] EX-100.CAL 6 frx-20080630_cal.xml XBRL TAXONOMY CALCULATION LINKBASE DOCUMENT -----END PRIVACY-ENHANCED MESSAGE-----